Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-06

Clinical Trial Update: Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion. [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial completed to evaluate whether consuming Ferric Hydroxide Adipate affects urinary phosphorus excretion, including participants with chronic kidney …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric Hydroxide Adipate (ferric hydroxide adipate)

Snippet

Sponsor: Medical Research Council | Conditions: Healthy, Chronic Kidney Diseases | EARLY_Phase 1 | Status: COMPLETED